SEQUELS AND FUNCTIONAL STATUS IN PATIENTS WITH PROLONGED COVID19

Main Article Content

Tatiana Isabel Vásquez Figueroa
https://orcid.org/0000-0002-4061-3675
Yu Ling Reascos Paredes
https://orcid.org/0000-0002-2103-9233
Paola Mishel Valverde Yacelga
https://orcid.org/0009-0009-4888-3256

Abstract

Introduction: Prolonged COVID-19 affects all systems of the organism, manifested by diverse signs and symptoms, which affect in the functionality of people overcome the infection. Objective: The aim of this study was to determine the sequelae and functional status in patients with prolonged covid-19 in the province of Imbabura. Methods: A quantitative, non-experimental, descriptive, retrospective and cross-sectional study. A sample of 322 elderly people with a positive diagnosis of COVID-19 was used. Results: Women and young adults were the largest analysis group in the research. It was identified that the age and schooling of the population represented a protective factor for overcoming sequelae more quickly and without limitations. Patients reported a sequelae duration of 1 to 3 months. The most affected system was the immune system, where low defenses reached the highest percentage (34.01%), followed by fatigue (29.34%), alopecia (25.80%), cough (22.79%), myalgia (22.75%), anxiety (20.05%), and anxiety (20.05%), 75%), anxiety (20.05%), headache (19.96%), anosmia (15.99%), sore throat (13.79%), chest palpitations (11.82%), abdominal pain (9.85%), and irregular menstrual cycle (8.68%). Conclusions: The results corroborate that more than half of the patients presented at least one symptom as a sequela, demonstrating the damage caused to the health of patients in the province. This emphasizes the need to strengthen public policies, research, follow-up, rehabilitation and treatment for patients with prolonged COVID-19.

Downloads

Download data is not yet available.

Article Details

How to Cite
Vásquez Figueroa, T. I., Reascos Paredes, Y. L., & Valverde Yacelga, P. M. (2024). SEQUELS AND FUNCTIONAL STATUS IN PATIENTS WITH PROLONGED COVID19. Enfermería Investiga, 9(2), 12–20. https://doi.org/10.31243/ei.uta.v9i2.2412.2024
Section
Artículo original

References

Correa E, Torrell G. COVID persistente. Elementos básicos para el médico de atención primaria. FMC. 2022; 29(9): 481-489. DOI: https://doi.org/10.1016/j.fmc.2022.02.015

Organización Mundial de la Salud (OMS). Enfermedad por coronavirus (COVID-19): afección posterior a la COVID-19. 2023. Disponible en: https://www.who.int/es/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition

World Health Organitacion. Post COVID-19 condition (Long COVID). 2022. Disponible en: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition

Tíscar V, Sánchez S, Lafuente A, Peña A, Twose M, Díaz S, et al. Vivencias e impacto en la calidad de vida de personas con COVID persistente. Gac Sanit. 2023; 37: 102247. DOI: https://doi.org/10.1016/j.gaceta.2022.102247

Wu Z, McGoogan J. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 2020; 323 (13): 1239–1242. DOI: https://doi.org/10.1001/jama.2020.2648

Peramo F, López M, López MA. Secuelas médicas de la COVID-19. Med Clin (Barc), 2021; 157(8): 388–394. DOI: https://doi.org/10.1016/j.medcli.2021.04.023

Tenforde M, Kim S, Lindsell C, Billig R, Shapiro N, Files D, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States March–June 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (30): 993-998. DOI: https://doi.org/10.15585/mmwr.mm6930e1

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. Consecuencias de 6 meses de COVID-19 en pacientes dados de alta del hospital: un estudio de cohorte. Lancet. 2021; 397 (10270): 220-232. DOI: https://doi.org/10.1016/S0140-6736(20)32656-8

Gárces I, Loor M, Alcocer S. Secuelas post-COVID-19 en adultos de Latinoamérica. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. 2023; 7 (1): 2778-2798. DOI: https://doi.org/10.56048/MQR20225.7.1.2023.2778-2798

González F. Post-COVID-19 conditions in Ecuadorian patients: an observational study. Lancet Reg Health Am. 2022; 5: 100088. DOI: https://doi.org/10.1016/j.lana.2021.100088

Abata A, Tonguino K, Nazate Z. Secuelas por COVID-19 en pacientes de 20 y 60 años que acuden al Centro de Salud “Tulcán Sur” de Ecuador. Revista de Ciencias Médicas de Pinar del Río. 2023; 27 (0). Disponible en: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/5990

Santander R, Valle M. Secuelas post covid en adultos atendidos en el Hospital San Luis de Otavalo 2021. La U Investiga. 2022; 9 (1): 10-20. DOI: https://doi.org/10.53358/lauinvestiga.v9i1.686

CDC CpeCylPdE. COVID-19. 2022. Disponible en: https://espanol.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html

Junta de Andalucía CDSYF. Vigilancia de la salud y seguimiento POST-COVID. 2021. Disponible en: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/sites/default/files/sincfiles/wsas-media-mediafile_sasdocumento/2021/AnexoIEncuesta.pdf

Siegerink B, Boon D, Barco S, Klok E, Le J. OSF HOME. 2023. Disponible en: https://osf.io/uhcbj

Association W–TWM. Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos. 2017. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/ .

López U, Bernal M, Gómez R. Síndrome COVID-19 persistente. Una revisión narrativa. Rev Clin Esp. 2022; 222 (4): 241-250. DOI: https://doi.org/10.1016/j.rceng.2021.10.001

Prieto M, Prieto O, Castro H. Covid prolongado: estudio de corte transversal. Rev Fac Cien Med Univ Nac Cordoba. 2021; 78 (1): 33-36. DOI: https://doi.org/10.31053/1853.0605.v78.n1.32048

Winheim E, Rinke L, Lutz K, Reischer A, Leutbecher A, Wolfram L, et al. Impaired function and delayed regeneration of dendritic cells in COVID-19. PLoS Pathog. 2021; 17 (10): 1009742. DOI: https://doi.org/10.1371/journal.ppat.1009742

Marsán V, Casado I, Hernández E. Respuesta inmune adaptativa en la infección por SARS-CoV-2. Revista Cubana de Hematología, Inmunología y Hemoterapia. 2020; 36(0). Disponible en: https://revhematologia.sld.cu/index.php/hih/article/view/1313

Peramo F, López M, López-Ruz M. Secuelas médicas de la COVID-19. Med Clin (Barc). 2021; 157 (8): 388-394. DOI: https://doi.org/10.1016/j.medcle.2021.04.008

Seeble J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Clinical Infectious Diseases Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022; 74 (7): 1191-1199. DOI: https://doi.org/10.1093/cid/ciab611

Papineau A, Broce A, Elcock E, Mariscal R, Rodríguez J, Santamaría J, et al. Manifestaciones clínicas en post COVID en adultos en la República de Panamá. Respirar. 2022; 14 (4): 215-211. DOI: https://doi.org/10.55720/respirar.14.4.6

Chérrez I, Gochicoa L, Salles A, Mautong H. Seguimiento de los pacientes después de neumonía por COVID-19. Secuelas pulmonares. Rev Alerg Mex. 2021; 67 (4). DOI: https://doi.org/10.29262/ram.v67i4.847

Carfí A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324 (6): 603-605. DOI: https://doi.org/10.1001/jama.2020.12603

Goicochea E, Córdova S, Gómez G, Villacorta J. Secuelas posteriores a la infección por COVID 19 en pacientes en el Hospital I Florencia de Mora. Trujillo, Perú. Rev. Fac. Med. Hum. 2022; 22 (4): 754-764. DOI: https://doi.org/10.25176/RFMH.v22i4.5045

Bouza E, Cantón R, De Lucas P, García A, Gómez J, González J, et al. Síndrome post-COVID: Un documento de reflexión y opinión. Rev Esp Quimioter. 2021; 34 (4): 269-279. DOI: https://doi.org/10.37201%2Freq%2F023.2021

Morin L, Savale L, Colle R, Figueiredo S, Harrois A, Pham T, et al. Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19. JAMA. 2021; 325 (15): 1525-34. DOI: https://doi.org/10.1001/jama.2021.3331

Ballering A, Zon S, Hartman T, Rosmalen J. Persistencia de síntomas somáticos después de COVID-19 en los Países Bajos: un estudio de cohorte observacional. Lancet. 2022; 400 (10350): 452-461. DOI: https://doi.org/10.1016/S0140-6736(22)01214-4

OPS/OMS. Organización Panamericana de la Salud. 2022. Disponible en: https://www.paho.org/es/noticias/29-6-2022-medida-que-casos-covid-19-siguen-aumentando-muchos-corren-riesgo-desarrollar .

ONU. Noticias ONU. 2021. Disponible en: https://news.un.org/es/story/2021/02/1488042

Gómez J, Álvarez M, Martín S, Javierre A. Papel protector de las actuales vacunas para las variantes del virus SARS-CoV-2 y la COVID persistente. FMC. 2022; 29 (1). DOI: https://doi.org/10.1016/j.fmc.2021.10.001

Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023; 41 (11). DOI: https://doi.org/10.1016/j.vaccine.2023.02.008

Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020; 370: 3026. DOI: https://doi.org/10.1136/bmj.m3026

Ranucci M, Baryshnikova E, Anguissola M, Pugliese S, Ranucci L, Falco M, et al. The Very Long COVID: Persistence of Symptoms after 12–18 Months from the Onset of Infection and Hospitalization. J Clin Med. 2023; 12 (5): 1915. DOI: https://doi.org/10.3390/jcm12051915

Tejada Y, Goicochea E, Guzmán O. Clinical epidemiological characteristics of patients diagnosed with SARS-CoV-2. Hospital I Florencia de Mora EsSalud – La Libertad, 2020. Rev.Fac.Med.Hum. 2021; 21 (4). DOI: https://doi.org/10.25176/RFMH.v21i4.3609

Balboa C, Lopez J, Muñoz N, Concha C, Oñat M, Briones J. Comorbidities associated with the risk of dying from COVID-19 in a cohort of patients admitted to a high complexity hospital. Medwave. 2021; 21 (2). Disponible en: https://www.medwave.cl/resumenescongreso/sp2021/enfinfeccemergreemerg/8289.html

Plasencia T, Aguilera R, Almaguer L. Comorbilidades y gravedad clínica de la COVID-19: revisión sistemática y meta-análisis. Rev haban cienc méd. 2020; 19 (0): 3389. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2020000400002

OPS. Long-term respiratory outcomes after COVID-19: a Brazilian cohort study. Rev Panam Salud Publica. 2022; 46 (106): 187. DOI: https://doi.org/10.26633/RPSP.2022.187

Tosato M, Carfì A, Martis I, Pais C, Ciciarello, F, Rota E, et al. Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study. J Am Med Dir Assoc. 2021; 22 (9): 1840-1844. DOI: https://doi.org/10.1016/j.jamda.2021.07.003

Similar Articles

<< < 4 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.